Two-Fraction SBRT Shows Acceptable Toxicity in Prostate Cancer Population

Two-fraction stereotactic body radiation therapy (SBRT) displayed feasibility and tolerability as a treatment for patients with intermediate/lower high-risk prostate cancer with visible gross tumor volume on multiparametric MRI compared with…

Continue Reading